Yuko Abe
Overview
Explore the profile of Yuko Abe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hashimoto K, Abe Y, Fukushima K, Matsumoto Y, Saito H, Akamine Y, et al.
Emerg Infect Dis
. 2025 Mar;
31(3):624-627.
PMID: 40023820
We identified 2 novel species, Mycobacterium novusgordonae and M. shingordonae, from sputum specimens of pulmonary disease patients in Japan. Genetic and biochemical analyses revealed a close relationship with M. paragordonae....
2.
Manullang C, Hanahara N, Tarigan A, Abe Y, Furukawa M, Morita M
BMC Genomics
. 2025 Jan;
26(1):36.
PMID: 39810102
Background: Rising seawater temperatures increasingly threaten coral reefs. The ability of coral larvae to withstand heat is crucial for maintaining reef ecosystems. Although several studies have investigated coral larvae's genetic...
3.
Abe Y, Matsuura H, Yamada A, Nakagawa R, Kojima H, Ishihara Y, et al.
Transfusion
. 2025 Jan;
65(2):354-362.
PMID: 39789834
Background: Ethylenediamine tetraacetate/glycine acid (EGA) and chloroquine diphosphate (CDP) are used in transfusion testing to dissociate IgG antibodies from red blood cells (RBCs). However, the ability of these reagents to...
4.
Hashimoto K, Abe Y, Fukushima K, Niitsu T, Komukai S, Miyamoto S, et al.
BMC Pulm Med
. 2024 Oct;
24(1):531.
PMID: 39448945
Background: The characteristics of bronchiectasis (BE) in Asia, including Japan, remain largely unknown. We aimed to provide insights into the clinical characteristics and treatment outcomes of BE, especially regarding nontuberculous...
5.
Fukushima K, Matsumoto Y, Abe Y, Hashimoto K, Motooka D, Kitada S, et al.
Antimicrob Agents Chemother
. 2024 Oct;
68(11):e0121324.
PMID: 39377582
This single-center retrospective study aimed to analyze the variability of macrolide resistance (MR) in 68 patients with complex pulmonary disease. Among 25 patients treated without macrolides, 13 (52%) reverted to...
6.
Nakagawa R, Matsuura H, Kojima H, Abe Y, Yamada A, Doi H, et al.
Lab Med
. 2024 Sep;
56(2):171-177.
PMID: 39306804
Background: Donor-specific antibodies (DSAs) targeting human leukocyte antigens (HLAs) substantially reduce the longevity of transplanted organs. Desensitization of DSA-positive renal transplant recipients is achieved through intravenous administration of immunoglobulin (IVIg)....
7.
Miyake K, Shiroyama T, Satoh S, Adachi Y, Ohira K, Abe Y, et al.
Respiration
. 2024 Feb;
103(4):205-213.
PMID: 38316121
Introduction: In transbronchial biopsy of peripheral pulmonary lesions, the bronchoscope can reach only a limited depth due to the progressive narrowing of bronchi, which may reduce the diagnostic rate. This...
8.
Kawano T, Gon Y, Sakaguchi M, Yamagami H, Abe S, Hashimoto H, et al.
J Am Heart Assoc
. 2024 Jan;
13(3):e032284.
PMID: 38240254
Background: Patients with acute ischemic stroke and active cancer have more severe neurological symptoms, elevated risks of stroke recurrence, and death compared with the general population. We examined whether von...
9.
Gon Y, Sakaguchi M, Yamagami H, Abe S, Hashimoto H, Ohara N, et al.
J Am Heart Assoc
. 2023 Jul;
12(15):e029618.
PMID: 37489755
Background Limited data exist on the prognostic factors for patients with ischemic stroke and active cancer. Methods and Results We conducted a prospective, multicenter, observational study in Japan, including patients...
10.
Nagatani K, Abe Y, Homma T, Fujii J, Suzuki T
Biochem Biophys Res Commun
. 2023 Apr;
663:71-77.
PMID: 37119768
Oxidative metabolism of rhododendrol (RD), a skin-whitening ingredient, by tyrosinase has caused leukoderma in a certain population of Japanese consumers. Toxic RD metabolites and reactive oxygen species are proposed causes...